← The library
Thymopentin
research/region-specificImmune/Anti-infEvidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
1
PurposeImmune
MechanismThymic peptide fragment studied for immune modulation
EffectsThymic peptide fragment studied for immune modulation
DosingNo human dose established.
Bottom linePopular in research/compounding; human safety/benefit not well-established.
Batches on filenone
No tested batches on file.
Cautions & interactions
Regulatory status varies
No well-established interaction profile for non-approved peptides; avoid combining multiple research compounds; discuss meds with clinician.
CV 1 of 5 — No solid direct cardiovascular outcomes evidence; any benefit is indirect or unproven.